News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

No Deaths During Clinical Trials: Biocon


10/19/2005 5:10:41 PM

Biotech firm Biocon India Ltd today clarified that there were no deaths during the clinical trials conducted by it in relation to its recombinant human insulin. Biocon Chairman and Managing Director Kiran Mazumdar-Shaw told mediapersons that the trials were conducted strictly in accordance with protocol based on internationally accepted standards and with the consent of all volunteers involved. "We wish to categorically state that no deaths occurred during the clinical trials conducted in relation to r-human insulin by Biocon," she said. "Not a single death occurred," Shaw said.

Read at India Daily

comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES